Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic rejection

P Koskinen1, K Lemström, P Häyry

  • 1Transplantation Laboratory, University of Helsinki, Finland.

Current Opinion in Nephrology and Hypertension
|May 1, 1996
PubMed
Summary

Chronic rejection, a major cause of graft loss, involves arteriosclerosis and inflammation. Optimizing immunosuppression with new drugs may prevent transplant arteriosclerosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Control of early Aspergillus mortality after lung transplantation: outcome and risk factors.

Transplantation proceedings·2010
Same author

Protocol core needle biopsy and histological chronic allograft damage index as surrogate endpoint for Long-Term graft survival.

Transplantation proceedings·2004
Same author

Rational drug design: making drugs that make a difference.

Transplantation proceedings·2002
Same author

Quantitation of cell migration in a rat carotid artery balloon injury model. Indications for a perivascular origin of the neointimal cells.

Cardiovascular drugs and therapy·2002
Same author

Expression of estrogen receptor sub-types alpha and beta in acute and chronic cardiac allograft vasculopathy.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2001
Same author

Estrogen receptor beta dominates in baboon carotid after endothelial denudation injury.

Molecular and cellular endocrinology·2001

Area of Science:

  • Nephrology
  • Immunology
  • Vascular Biology

Background:

  • Chronic rejection is a leading cause of long-term organ transplant failure.
  • Acute rejection episodes correlate with increased risk of chronic rejection and graft loss.
  • The hallmark of chronic rejection is transplant arteriosclerosis, affecting allograft vasculature.

Purpose of the Study:

  • To review current understanding of chronic renal allograft rejection.
  • To highlight risk factors, pathogenesis, and prevention strategies.
  • To discuss animal models for studying chronic rejection.

Main Methods:

  • Review of existing literature on chronic rejection.
  • Analysis of cellular and molecular mechanisms.
  • Discussion of in-vitro and in-vivo study findings.

Main Results:

  • Chronic rejection involves complex immunological, metabolic, and hemodynamic factors.
  • Vascular smooth muscle cell proliferation and migration drive arteriosclerosis.
  • Inflammatory cells and mediators contribute to vascular wall remodeling.

Conclusions:

  • Optimizing immunosuppression is crucial for preventing chronic rejection.
  • Novel immunosuppressive drugs may offer direct benefits against transplant arteriosclerosis.
  • Further research using animal models is needed to understand cellular and molecular pathways.

Related Experiment Videos